Jarry Olivier Roger 4

What Happened

• Jarry Olivier Roger, a director of OS Therapies Inc. (OSTX), was granted options to purchase 50,000 shares of the company's common stock on January 22, 2026. The Form 4 reports the award as a derivative grant with $0 cash paid on grant.
• The options vest in full on the one-year anniversary of the grant date, provided Roger remains a director on that date (per the footnote). The filing does not disclose an exercise price in the excerpt provided.

Key Details

• Transaction date: 2026-01-22; Form 4 filed: 2026-02-13 (appears to be filed after the typical 2-business-day window).
• Transaction type/code: Award/Grant (A) — stock option grant (derivative).
• Shares/options granted: 50,000 option awards reported; reported acquisition value: $0.
• Shares owned after transaction: Not stated in the provided excerpt of the filing.
• Footnote: Options vest in full on the one-year anniversary if the reporting person is serving as a director on that date.
• Filing timeliness: Filing date is Feb 13 for a Jan 22 grant — appears late (may warrant attention for timeliness).

Context

• This was an option grant (compensation/award), not an open-market purchase or sale — it does not represent immediate stock ownership or a cash investment by the insider. Options must be exercised (and vested) before becoming actual shares that could be sold.
• Such grants are routine for directors and executives as part of compensation; they are informational but do not by themselves indicate that the insider bought or sold shares.